
We are placing Philips PHG under review as we update our operating assumptions.
By Stephen Simpson : Big deals understandably make investors nervous, but when the buyer in question already has a record and reputation for overpaying in deals and failing to reap all of the promised benefits, it's so much the worse. That's the burden on Hologic ( HOLX ) now that it has announced
million, it shadows both General Electric and Citigroup with its earnings per share of $.8.77. Competitors like Phillips ( PHG ) and Smith Group ( SMIN ) trail behind with no hopes of getting back in the race. In reality, I don't Complete Story »
Philips PHG delivered first-quarter results that were better than we anticipated, though we are unlikely to change our fair value estimate
Wall Street Breakfast Editors submit: Top Stories Baby Love for Nestle as it wins $11.85B Pfizer ops. Nestle ( NSRGY.PK ) has won the race to acquire Pfizer's ( PFE ) baby food unit after agreeing to pay $11.85B in cash for the operations. The acquisition will enable Nestle to expand its ...
Philips Electronics ( PHG ): Q1 net profit of €248M, lifted by higher sales and margins. Sales +7% to €5.6B vs. expectations of €5.42B. Philips plans to cut 4,500 jobs and to deliver €800M in savings by 2014. ( PR ) Post your comment!
Welcome to the Royal Philips Electronics First Quarter Results 2012 Conference Call on Monday 23rd of April, 2012. During the introduction hosted my Mr. Frans van Houten, CEO, and Mr. Ron Wirahadiraksa, CFO, all participants will be in a listen-only mode. After the introduction, there will be an ...
technological advantages in LED material production. Current leaders in the traditional lighting industry include Royal Philips Group PHG and Osram, a division of Siemens SI, firms with nearly endless resources that could invest heavily in competing products
After a months-long search, Quest Diagnostics DGX announced its new CEO would be Stephen Rusckowski, current head of Philips PHG Healthcare. While we think it is long overdue for current CEO Surya Mohapatra to step down, we are withholding judgment on
growing at above-industry rates, and unlike most of its peers, its growth has been largely internal. Siemens SI, Philips PHG , Abbott ABT, and Danaher DHR have become dominant players in the med tech mainly through sizable acquisitions over the past